SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment
Clarisse Marotz,
Pedro Belda-Ferre,
Farhana Ali,
Promi Das,
Shi Huang,
Kalen Cantrell,
Lingjing Jiang,
Cameron Martino,
Rachel E. Diner,
Gibraan Rahman,
Daniel McDonald,
George Armstrong,
Sho Kodera,
Sonya Donato,
Gertrude Ecklu-Mensah,
Neil Gottel,
Mariana C. Salas Garcia,
Leslie Y. Chiang,
Rodolfo A. Salido,
Justin P. Shaffer,
Mac Kenzie Bryant,
Karenina Sanders,
Greg Humphrey,
Gail Ackermann,
Niina Haiminen,
Kristen L. Beck,
Ho-Cheol Kim,
Anna Paola Carrieri,
Laxmi Parida,
Yoshiki Vázquez-Baeza,
Francesca J. Torriani,
Rob Knight,
Jack Gilbert,
Daniel A. Sweeney,
Sarah M. Allard
Affiliations
Clarisse Marotz
Department of Pediatrics, School of Medicine, University of California San Diego
Pedro Belda-Ferre
Department of Pediatrics, School of Medicine, University of California San Diego
Farhana Ali
Department of Pediatrics, School of Medicine, University of California San Diego
Promi Das
Department of Pediatrics, School of Medicine, University of California San Diego
Shi Huang
Department of Pediatrics, School of Medicine, University of California San Diego
Kalen Cantrell
Center for Microbiome Innovation, Jacobs School of Engineering, University of California San Diego
Lingjing Jiang
Center for Microbiome Innovation, Jacobs School of Engineering, University of California San Diego
Cameron Martino
Department of Pediatrics, School of Medicine, University of California San Diego
Rachel E. Diner
Department of Pediatrics, School of Medicine, University of California San Diego
Gibraan Rahman
Department of Pediatrics, School of Medicine, University of California San Diego
Daniel McDonald
Department of Pediatrics, School of Medicine, University of California San Diego
George Armstrong
Department of Pediatrics, School of Medicine, University of California San Diego
Sho Kodera
Department of Pediatrics, School of Medicine, University of California San Diego
Sonya Donato
Microbiome Core, School of Medicine, University of California San Diego
Gertrude Ecklu-Mensah
Department of Pediatrics, School of Medicine, University of California San Diego
Neil Gottel
Department of Pediatrics, School of Medicine, University of California San Diego
Mariana C. Salas Garcia
Department of Pediatrics, School of Medicine, University of California San Diego
Leslie Y. Chiang
Department of Pediatrics, School of Medicine, University of California San Diego
Rodolfo A. Salido
Infection Prevention and Clinical Epidemiology Unit at UC San Diego Health, Division of Infectious Diseases and Global Public Health, Department of Medicine, UC San Diego
Justin P. Shaffer
Department of Pediatrics, School of Medicine, University of California San Diego
Mac Kenzie Bryant
Department of Pediatrics, School of Medicine, University of California San Diego
Karenina Sanders
Department of Pediatrics, School of Medicine, University of California San Diego
Greg Humphrey
Department of Pediatrics, School of Medicine, University of California San Diego
Gail Ackermann
Department of Pediatrics, School of Medicine, University of California San Diego
Niina Haiminen
IBM, T.J Watson Research Center, Yorktown Heights
Kristen L. Beck
AI and Cognitive Software, IBM Research-Almaden
Ho-Cheol Kim
AI and Cognitive Software, IBM Research-Almaden
Anna Paola Carrieri
IBM Research UK, The Hartree Centre
Laxmi Parida
IBM, T.J Watson Research Center, Yorktown Heights
Yoshiki Vázquez-Baeza
Center for Microbiome Innovation, Jacobs School of Engineering, University of California San Diego
Francesca J. Torriani
Infection Prevention and Clinical Epidemiology Unit at UC San Diego Health, Division of Infectious Diseases and Global Public Health, Department of Medicine, UC San Diego
Rob Knight
Department of Pediatrics, School of Medicine, University of California San Diego
Jack Gilbert
Department of Pediatrics, School of Medicine, University of California San Diego
Daniel A. Sweeney
Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of California San Diego
Sarah M. Allard
Department of Pediatrics, School of Medicine, University of California San Diego
Abstract Background SARS-CoV-2 is an RNA virus responsible for the coronavirus disease 2019 (COVID-19) pandemic. Viruses exist in complex microbial environments, and recent studies have revealed both synergistic and antagonistic effects of specific bacterial taxa on viral prevalence and infectivity. We set out to test whether specific bacterial communities predict SARS-CoV-2 occurrence in a hospital setting. Methods We collected 972 samples from hospitalized patients with COVID-19, their health care providers, and hospital surfaces before, during, and after admission. We screened for SARS-CoV-2 using RT-qPCR, characterized microbial communities using 16S rRNA gene amplicon sequencing, and used these bacterial profiles to classify SARS-CoV-2 RNA detection with a random forest model. Results Sixteen percent of surfaces from COVID-19 patient rooms had detectable SARS-CoV-2 RNA, although infectivity was not assessed. The highest prevalence was in floor samples next to patient beds (39%) and directly outside their rooms (29%). Although bed rail samples more closely resembled the patient microbiome compared to floor samples, SARS-CoV-2 RNA was detected less often in bed rail samples (11%). SARS-CoV-2 positive samples had higher bacterial phylogenetic diversity in both human and surface samples and higher biomass in floor samples. 16S microbial community profiles enabled high classifier accuracy for SARS-CoV-2 status in not only nares, but also forehead, stool, and floor samples. Across these distinct microbial profiles, a single amplicon sequence variant from the genus Rothia strongly predicted SARS-CoV-2 presence across sample types, with greater prevalence in positive surface and human samples, even when compared to samples from patients in other intensive care units prior to the COVID-19 pandemic. Conclusions These results contextualize the vast diversity of microbial niches where SARS-CoV-2 RNA is detected and identify specific bacterial taxa that associate with the viral RNA prevalence both in the host and hospital environment. Video Abstract